Table 7 Type of chemotherapy administered in 127 patients with pT1a, pT1b breast cancers
From: Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study
All pts (N = 127) | pT1a pts (=27) | pT1b pts (N = 100) | |
|---|---|---|---|
Regimen | |||
CMF-like | 18/127 (14.2%) | 3/27 (11.1%) | 15/100 (15%) |
Anthracycline without taxane | 75/127 (59.1%) | 21/27 (77.8%) | 54/100 (54%) |
Anthracycline with taxane | 31/127 (24.4%) | 3/27 (11.1%) | 28/100 (28%) |
Taxane without anthracycline | 3/127 (2.4%) | 0 | 3/100 (3%) |